S902 Intestinal Ultrasound Response and Transmural Remission After 48 Weeks of Treatment With Ustekinumab in Crohn’s Disease: STARDUST Trial Substudy Results by Line of Treatment and by Location

Autor:	Giovanni Maconi, Ivana Bravatà, Rose Vaughan, Floris de Voogd, Christian Maaser, Carolina Palmela, M Lahaye, Nadezda Machkova, Manuela Le Bars, Lioudmila Ni, Mariangela Allocca, Elena Ercole, Rune Wilkens, M Nazar, Maria Antonietta D'Agostino, Torsten Kucharzik
Rok vydání:	2021
Předmět:	medicine.medical_specialty Crohn's disease Hepatology business.industry Ultrasound Gastroenterology medicine.disease Internal medicine Ustekinumab medicine Line (text file) business medicine.drug
Zdroj:	American Journal of Gastroenterology. 116:S426-S426
ISSN:	1572-0241 0002-9270
DOI:	10.14309/01.ajg.0000777140.83650.94
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4032d5c5b8739b0da96a5bb4fd5fe63d https://doi.org/10.14309/01.ajg.0000777140.83650.94 Zobrazit plný text záznamu